XML 34 R22.htm IDEA: XBRL DOCUMENT
v3.25.2

Earnings (Loss) per Share (Tables) | 6 Months Ended
--- | ---
Jun. 30, 2025
Earnings Per Share [Abstract] |
Schedule of Computation of Basic and Diluted Earnings (Loss) Per Share of Common Stock | The following table sets forth the computation of basic and diluted earnings (loss) per share of common stock for the three and six months ended June 30, 2025 and 2024: Schedule of Computation of Basic and Diluted Earnings (Loss) Per Share of Common Stock
|  | 2025 |  |  | 2024 |  |  | 2025 |  |  | 2024 |
|  | Three Months Ended June 30, |  |  | Six Months Ended June 30, |
|  | 2025 |  |  | 2024 |  |  | 2025 |  |  | 2024 |
Basic earnings (loss) per share attributable to common stock: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Numerator |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Net income (loss) |  | $ | (2,205,716 | ) |  | $ | (3,068,634 | ) |  | $ | (4,070,589 | ) |  | $ | 444,987 |
Denominator |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Weighted avg. common shares outstanding |  |  | 5,351,957 |  |  |  | 5,343,922 |  |  |  | 5,350,267 |  |  |  | 5,329,876 |
Basic earnings (loss) per share attributable to common stock |  | $ | (0.41 | ) |  | $ | (0.57 | ) |  | $ | (0.76 | ) |  | $ | 0.08 |
Diluted earnings (loss) per share attributable to common stock: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Numerator |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Net income (loss) |  | $ | (2,205,716 | ) |  | $ | (3,068,634 | ) |  | $ | (4,070,589 | ) |  | $ | 444,987 |
Effect of dilutive securities on net earnings (loss): |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Common stock warrants |  |  | - |  |  |  | (84,430 | ) |  |  | - |  |  |  | (124,502 | )
Total net income (loss) for purpose of calculating diluted net income |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
(loss) per common share |  | $ | (2,205,716 | ) |  | $ | (2,984,204 | ) |  | $ | (4,070,589 | ) |  | $ | 569,489 |
Total net income (loss) for purpose of calculating diluted net income (loss) per common share |  | $ | (2,205,716 | ) |  | $ | (2,984,204 | ) |  | $ | (4,070,589 | ) |  | $ | 569,489 |
Denominator |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Weighted avg. common shares outstanding |  |  | 5,351,957 |  |  |  | 5,343,922 |  |  |  | 5,350,267 |  |  |  | 5,329,876 |
Weighted average effect of dilutive securities: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stock options |  |  | - |  |  |  | - |  |  |  | - |  |  |  | 122,074 |
Warrants |  |  | - |  |  |  | - |  |  |  | - |  |  |  | 7,254 |
Dilutive securities |  |  | - |  |  |  | - |  |  |  | - |  |  |  | 7,254 |
Total shares for purpose of calculating diluted net earnings (loss) per common share |  |  | 5,351,957 |  |  |  | 5,343,922 |  |  |  | 5,350,267 |  |  |  | 5,459,204 |
Diluted earnings (loss) per share attributable to common stock |  | $ | (0.41 | ) |  | $ | (0.56 | ) |  | $ | (0.76 | ) |  | $ | 0.10 |
Schedule of Anti-dilutive Securities Excluded from Computation of Earnings Per Share | The computation of diluted loss per share for the three and six months ended June 30, 2025 and 2024 does not include the following stock options and warrants to purchase shares of common stock or unvested restricted stock units in the computation of diluted earnings (loss) per share because these instruments were antidilutive: Schedule of Anti-dilutive Securities Excluded from Computation of Earnings Per Share
|  | 2025 |  |  | 2024 |  |  | 2025 |  |  | 2024 |
|  | For the Three Months Ended |  |  | For the Six Months Ended |
|  | June 30, |  |  | June 30, |
|  | 2025 |  |  | 2024 |  |  | 2025 |  |  | 2024 |
Stock options |  |  | 354,908 |  |  |  | 295,517 |  |  |  | 354,908 |  |  |  | 173,443 |
Unvested restricted stock units |  |  | 19,346 |  |  |  | 21,762 |  |  |  | 19,346 |  |  |  | 14,508 |
Warrants |  |  | - |  |  |  | 49,333 |  |  |  | - |  |  |  | 49,433 |
Antidilutive securities excluded from computation of earnings per share, amount |  |  | - |  |  |  | 49,333 |  |  |  | - |  |  |  | 49,433 |

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1 + Details
Name: | us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1 + Details
Name: | us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration